Abstract

The global reach of Japanese Encephalitis Virus (JEV) with an estimated 3 billion people at risk makes this virus a severe threat to the public health. Since its first detection in 1955, this virus has managed to spread throughout the country. Understanding the molecular epidemiology of Japanese Encephalitis Virus in India will help in designing vaccine strategies for preventive initiatives necessary to control the Acute Encephalitis Syndrome (AES) the main implication of the infection caused by the Japanese Encephalitis Virus (JEV).

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call